Martek Announces Fourth Quarter and FY 2007 Financi...(non-GAAP financial measure included here...)

Three months ended Year ended

October 31, October 31,

2007 2006 2007 2006

Net income, as reported under GAAP $18,268 $102 $32,013 $14,938

Deduct: Tax benefit from reversal

of deferred tax asset

valuation allowance (10,841) - (10,841) -

Add: Restructuring charge 106 4,729 853 4,729

Deduct: Tax benefit of

restructuring charge (38) (1,726) (307) (1,726)

Non-GAAP net income measure $7,495 $3,105 $21,718 $17,941

Non-GAAP diluted earnings per share $0.23 $0.10 $0.67 $0.55

Investor Conference Call Webcast

Martek will host a conference call and Webcast for investors to review its fourth quarter results and fiscal 2008 outlook at 4:45 p.m. Eastern Time on Wednesday, December 12, 2007. Access to the live audio Webcast is available through Martek's website at http://investors.martek.com. The webcast will be available for replay through the close of business on January 12, 2008.

General

Sections of this release contain forward-looking statements concerning, among other things: (1) Martek's expectations regarding future revenue growth in and customer demand from the infant formula, pregnancy and nursing, nutritional supplements and food and beverage markets; (2) its expectations regarding revenues, profitability, cash flows from operations and changes in inventory levels during fiscal 2008; (3) statements regarding specific revenue, gross margin and income expectations for the first quarter of fiscal 2008; (4) statements regarding customer supply arrangements and pricing; (4) e
'/>"/>